Skip to content

Insider · CIK 0001877774

Saleem Elmasri

directorcfoofficer

Files at LBSR (LIBERTY STAR URANIUM & METALS CORP.), JUNS (JUPITER NEUROSCIENCES, INC.). First filing Mar 5, 2025, latest Mar 5, 2025.

Saleem Elmasri files SEC Form 4 as director and CFO at LBSR (LIBERTY STAR URANIUM & METALS CORP.), and also at JUNS (JUPITER NEUROSCIENCES, INC.). Since Mar 5, 2025, Saleem Elmasri has reported 1 open-market buy worth $15k and 0 open-market sells worth $0, the latest filed on Mar 5, 2025.

A track record needs three past buys with six months of prices behind them; Saleem Elmasri has 0, so none is measured yet.

The newest scored trade: bought $15k of LBSR on Mar 5, 2025, filed Mar 5, 2025, scored 38 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$15k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LBSR: LIBERTY STAR URANIUM & METALS CORP.

LBSROct 9, 2026 · close 0.02

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
LBSRbuy 4
LIBERTY STAR URANIUM & METALS CORP.
$15k
166,667 shares
--

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 2, 2026JUNS
JUPITER NEUROSCIENCES, INC.
AGrant or award
Stock Optionderivative
+525,565$0.00$0525,565Jun 4, 2026
Aug 20, 2025LBSR
LIBERTY STAR URANIUM & METALS CORP.
AGrant or award
Non Qualified stock Optionsderivative
+500,000$0.07$35k500,000Aug 22, 2025
Jun 2, 2025JUNS
JUPITER NEUROSCIENCES, INC.
MOption exercise
Common Stock
+66,293$0.00$066,239Jul 7, 2025
Jul 2, 2025JUNS
JUPITER NEUROSCIENCES, INC.
AGrant or award
Stock Option (right to buy)derivative
+102,128--102,128Jul 7, 2025
Mar 5, 2025LBSR
LIBERTY STAR URANIUM & METALS CORP.
POpen-market purchase
Common Stock
+166,667$0.09$15k166,667Mar 5, 2025
Mar 5, 2025LBSR
LIBERTY STAR URANIUM & METALS CORP.
POpen-market purchase
Warrantsderivative
+83,334$0.09$7,50083,334Mar 5, 2025
Jan 29, 2025LBSR
LIBERTY STAR URANIUM & METALS CORP.
AGrant or award
Non Qualified stock Optionsderivative
+291,667$0.12$35k291,667Jan 31, 2025

Questions about Saleem Elmasri

Answered from the filings on this page, as of the latest one.

Is Saleem Elmasri buying or selling?

Not in the last 12 months. Saleem Elmasri's latest open-market trade on SEC Form 4 was bought $15k of LBSR on Mar 5, 2025.

How did Saleem Elmasri's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Saleem Elmasri has 0.

Where does Saleem Elmasri file Form 4?

Saleem Elmasri has filed Form 4 at LBSR (LIBERTY STAR URANIUM & METALS CORP.); JUNS (JUPITER NEUROSCIENCES, INC.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Saleem Elmasri: insider trades and track record | InsiderTell